VICTOR EDUARDO MULANOVICH to Anti-Bacterial Agents
This is a "connection" page, showing publications VICTOR EDUARDO MULANOVICH has written about Anti-Bacterial Agents.
Connection Strength
0.543
-
Emergence of linezolid-resistant coagulase-negative Staphylococcus in a cancer centre linked to increased linezolid utilization. J Antimicrob Chemother. 2010 Sep; 65(9):2001-4.
Score: 0.153
-
Clinical presentation and outcomes of non-typhoidal Salmonella infections in patients with cancer. BMC Infect Dis. 2021 Sep 29; 21(1):1021.
Score: 0.084
-
Graft loss attributed to possible transfusion-transmitted ehrlichiosis following cord blood stem cell transplant. Transpl Infect Dis. 2018 Aug; 20(4):e12899.
Score: 0.066
-
Successful Salvage of Central Venous Catheters in Patients with Catheter-Related or Central Line-Associated Bloodstream Infections by Using a Catheter Lock Solution Consisting of Minocycline, EDTA, and 25% Ethanol. Antimicrob Agents Chemother. 2016 06; 60(6):3426-32.
Score: 0.058
-
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer. Antimicrob Agents Chemother. 2016 01; 60(1):239-44.
Score: 0.055
-
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center. Oncologist. 2012; 17(10):1329-36.
Score: 0.044
-
Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010 Aug; 36(2):182-6.
Score: 0.038
-
Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore). 2009 Jul; 88(4):211-220.
Score: 0.036
-
Escherichia coli Pyomyositis: an emerging infectious disease among patients with hematologic malignancies. Clin Infect Dis. 2010 Feb 01; 50(3):374-80.
Score: 0.009